In the week since we published our overview of the healthcare industry’s counter attack on Covid-19, the situation has escalated rapidly - cases have accelerated and global governments have taken a tougher stance. Meanwhile, scientists' understanding of the disease continues to expand, giving pharma companies more ammunition as they mount a fightback.
We have therefore decided to update our overview of the situation, in an article which you can read here.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis